G'day Moosey, no the patent is not solely directed at Covid-19. The patent is for a variety of viruses, but notably includes a broad range of past, current and new Coronaviruses - Covid-19 falling into the category of "new" coronavirus at time of publication, as such. I would imagine that testing on Covid-19 would be therefore be covered within this patent, at least until a possible next stage is reached, and a new more definitive patent is filed by BIT, the owner of the other compound (after purchasing some sort of rights to BIT and Vice Versa), or both.
https://patents.google.com/patent/US20190389816A1/en?q=biotron&oq=biotron&sort=new
Brainstorming, page-51
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.002(6.25%) |
Mkt cap ! $28.87M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 3.0¢ | $7.079K | 235.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 123905 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 361155 | 3 |
View Market Depth
| Last trade - 10.06am 30/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |